Search details
1.
The influence of immunodeficiency, disease features, and patient characteristics on survival in plasmablastic lymphoma.
Blood
; 143(2): 152-165, 2024 Jan 11.
Article
in English
| MEDLINE | ID: mdl-37832030
2.
Personalised therapy in follicular lymphoma - is the dial turning?
Hematol Oncol
; 2023 Jul 22.
Article
in English
| MEDLINE | ID: mdl-37482955
3.
Dose escalation of subcutaneous epcoritamab in patients with relapsed or refractory B-cell non-Hodgkin lymphoma: an open-label, phase 1/2 study.
Lancet
; 398(10306): 1157-1169, 2021 09 25.
Article
in English
| MEDLINE | ID: mdl-34508654
4.
Diagnosis and management of mantle cell lymphoma: A British Society for Haematology Guideline.
Br J Haematol
; 204(1): 108-126, 2024 01.
Article
in English
| MEDLINE | ID: mdl-37880821
5.
A phase II study to assess the safety and efficacy of the dual mTORC1/2 inhibitor vistusertib in relapsed, refractory DLBCL.
Hematol Oncol
; 37(4): 352-359, 2019 Oct.
Article
in English
| MEDLINE | ID: mdl-31385336
6.
International multicenter retrospective analysis of thiotepa-based autologous stem cell transplantation for secondary central nervous system lymphoma.
Haematologica
; 108(3): 882-888, 2023 03 01.
Article
in English
| MEDLINE | ID: mdl-36300776
7.
Results of a multicentre UK-wide retrospective study evaluating the efficacy of brentuximab vedotin in relapsed, refractory classical Hodgkin lymphoma in the transplant naive setting.
Br J Haematol
; 179(3): 471-479, 2017 11.
Article
in English
| MEDLINE | ID: mdl-28857136
8.
Results of a multicentre UK-wide retrospective study evaluating the efficacy of pixantrone in relapsed, refractory diffuse large B cell lymphoma.
Br J Haematol
; 173(6): 896-904, 2016 06.
Article
in English
| MEDLINE | ID: mdl-26956150
9.
Automated prognostic pattern detection shows favourable diffuse pattern of FOXP3(+) Tregs in follicular lymphoma.
Br J Cancer
; 113(8): 1197-205, 2015 Oct 20.
Article
in English
| MEDLINE | ID: mdl-26439683
10.
Safety of bendamustine for the treatment of indolent non-Hodgkin lymphoma: a UK real-world experience.
Blood Adv
; 8(4): 878-888, 2024 Feb 27.
Article
in English
| MEDLINE | ID: mdl-37967358
11.
Epcoritamab monotherapy in patients with relapsed or refractory follicular lymphoma (EPCORE NHL-1): a phase 2 cohort of a single-arm, multicentre study.
Lancet Haematol
; 2024 Jun 13.
Article
in English
| MEDLINE | ID: mdl-38889737
12.
Safety and efficacy of zanubrutinib in relapsed/refractory marginal zone lymphoma: final analysis of the MAGNOLIA study.
Blood Adv
; 7(22): 6801-6811, 2023 11 28.
Article
in English
| MEDLINE | ID: mdl-37682792
13.
Long-term efficacy, safety and neurotolerability of MATRix regimen followed by autologous transplant in primary CNS lymphoma: 7-year results of the IELSG32 randomized trial.
Leukemia
; 36(7): 1870-1878, 2022 07.
Article
in English
| MEDLINE | ID: mdl-35562406
14.
Systemic ALCL Treated in Routine Clinical Practice: Outcomes Following First-Line Chemotherapy from a Multicentre Cohort.
Adv Ther
; 38(7): 3789-3802, 2021 07.
Article
in English
| MEDLINE | ID: mdl-34037958
15.
A phase 1/2 study of thiotepa-based immunochemotherapy in relapsed/refractory primary CNS lymphoma: the TIER trial.
Blood Adv
; 5(20): 4073-4082, 2021 10 26.
Article
in English
| MEDLINE | ID: mdl-34464973
16.
A phase II trial of AZD1152 in relapsed/refractory diffuse large B-cell lymphoma.
Br J Haematol
; 170(6): 886-90, 2015 Sep.
Article
in English
| MEDLINE | ID: mdl-25721307
17.
Fractures are common within 18 months following first-line R-CHOP in older patients with diffuse large B-cell lymphoma.
Blood Adv
; 4(18): 4337-4346, 2020 09 22.
Article
in English
| MEDLINE | ID: mdl-32915975
18.
RIVA - a phase IIa study of rituximab and varlilumab in relapsed or refractory B-cell malignancies: study protocol for a randomized controlled trial.
Trials
; 19(1): 619, 2018 Nov 09.
Article
in English
| MEDLINE | ID: mdl-30413184
19.
A Phase 2/3 Multicenter, Randomized, Open-Label Study to Compare the Efficacy and Safety of Lenalidomide Versus Investigator's Choice in Patients with Relapsed or Refractory Diffuse Large B-Cell Lymphoma.
Clin Cancer Res
; 23(15): 4127-4137, 2017 Aug 01.
Article
in English
| MEDLINE | ID: mdl-28381416
20.
Whole-brain radiotherapy or autologous stem-cell transplantation as consolidation strategies after high-dose methotrexate-based chemoimmunotherapy in patients with primary CNS lymphoma: results of the second randomisation of the International Extranodal Lymphoma Study Group-32 phase 2 trial.
Lancet Haematol
; 4(11): e510-e523, 2017 Nov.
Article
in English
| MEDLINE | ID: mdl-29054815